Lipoprotein Apheresis Shows Durable Impact on CV Outcomes Lipoprotein Apheresis Shows Durable Impact on CV Outcomes

Giving very high-risk dyslipidemia patients lipoprotein apheresis dramatically reduces their risk for cardiovascular (CV) and noncardiovascular events, show ' unique ' 7-year Germany registry data.Medscape Medical News
Source: Medscape Pulmonary Medicine Headlines - Category: Respiratory Medicine Tags: Cardiology News Source Type: news